Tomoji Mashimo

6.3k total citations
138 papers, 3.7k citations indexed

About

Tomoji Mashimo is a scholar working on Molecular Biology, Genetics and Cellular and Molecular Neuroscience. According to data from OpenAlex, Tomoji Mashimo has authored 138 papers receiving a total of 3.7k indexed citations (citations by other indexed papers that have themselves been cited), including 88 papers in Molecular Biology, 38 papers in Genetics and 31 papers in Cellular and Molecular Neuroscience. Recurrent topics in Tomoji Mashimo's work include CRISPR and Genetic Engineering (31 papers), Neuroscience and Neuropharmacology Research (19 papers) and Pluripotent Stem Cells Research (15 papers). Tomoji Mashimo is often cited by papers focused on CRISPR and Genetic Engineering (31 papers), Neuroscience and Neuropharmacology Research (19 papers) and Pluripotent Stem Cells Research (15 papers). Tomoji Mashimo collaborates with scholars based in Japan, France and United States. Tomoji Mashimo's co-authors include Takehito Kaneko, Kazuto Yoshimi, Birger Voigt, Tadao Serikawa, Takashi Yamamoto, Yayoi Kunihiro, Tetsushi Sakuma, Takashi Kuramoto, Marianne Lucas and Akiko Takizawa and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Communications.

In The Last Decade

Tomoji Mashimo

130 papers receiving 3.7k citations

Peers

Countries citing papers authored by Tomoji Mashimo

Since Specialization

Citations

This map shows the geographic impact of Tomoji Mashimo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tomoji Mashimo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tomoji Mashimo more than expected).

Fields of papers citing papers by Tomoji Mashimo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tomoji Mashimo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tomoji Mashimo. The network helps show where Tomoji Mashimo may publish in the future.

Co-authorship network of co-authors of Tomoji Mashimo

This figure shows the co-authorship network connecting the top 25 collaborators of Tomoji Mashimo. A scholar is included among the top collaborators of Tomoji Mashimo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tomoji Mashimo. Tomoji Mashimo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Divergent effects of premineralization and prevascularization on osteogenesis and vascular integration in humanized tissue engineered bone constructs 2025 ·Acta Biomaterialia ·(unknown), (unknown), (unknown), (unknown), (unknown), Kamil A. Sokolowski, Tomoji Mashimo, Nathalie Bock, Jacqui McGovern	0
2	Susceptibility of Brca1^(L63X/+) rat to ovarian reserve dissipation by chemotherapeutic agents to breast cancer 2025 ·Cancer Science ·(unknown), (unknown), Yashiro Motooka, (unknown), Tomoko Nakamura, Satoko Osuka, Shinya Akatsuka, Hiroaki Kajiyama, Tomoji Mashimo, Tatsuhiko Imaoka, Shinya Toyokuni	1
3	Nrf2-and p53-inducible REDD2/DDiT4L/Rtp801L confers pancreatic β-cell dysfunction, leading to glucose intolerance in high-fat diet-fed mice 2025 ·Journal of Biological Chemistry ·(unknown), Norimoto URAKAWA, H Tamiya, (unknown), Hiroki Takahashi, Naoki Harada, Tomoya Kitakaze, Takeshi Izawa, Shigenobu Matsumura, Eiji Yoshihara, Hiroshi Inui, Tomoji Mashimo, Ryoichi Yamaji	0
4	Diverse Cre recombinase expression pattern in Albumin-Cre driver rats 2025 ·EXPERIMENTAL ANIMALS ·Saeko Ishida, Keiko Taguchi, (unknown), (unknown), (unknown), Kazuto Yoshimi, Masayuki Yamamoto, Tomoji Mashimo	0
5	Iron-catalyzed oxidative stress compromises cancer promotional effect of BRCA2 haploinsufficiency through mitochondria-targeted ferroptosis 2025 ·Redox Biology ·Yuki Maeda, Yashiro Motooka, Shinya Akatsuka, (unknown), Tomoji Mashimo, Shinya Toyokuni	1
6	Brca2 ^{(p.T1942fs/+)} dissipates ovarian reserve in rats through oxidative stress in follicular granulosa cells 2024 ·Free Radical Research ·(unknown), Yashiro Motooka, Yuki Maeda, (unknown), Tomoko Nakamura, Hiroaki Kajiyama, Tomoji Mashimo, Shinya Toyokuni	2
7	Mammalian genome research resources available from the National BioResource Project in Japan 2024 ·Mammalian Genome ·(unknown), Shoko Kawamoto, Masahide Asano, Tomoji Mashimo, Shigeharu Wakana, Katsuki Nakamura, Ken‐ichi Nishijima, Hitoshi Okamoto, Kuniaki Saito, Sawako Yoshina, Yoshihiro Miwa, Yukio Nakamura, Moriya Ohkuma, Atsushi Yoshiki	0
8	Immune deficiency phenotypes of Il2rg, Rag2 or Il2rg/Rag2 double knockout rats; establishment of human leukemia xenograft models 2024 ·SHILAP Revista de lepidopterología ·(unknown), (unknown), Euna Kwon, Tomoji Mashimo, Byeong-Cheol Kang	1
9	A missense mutation in the Hspa8 gene encoding heat shock cognate protein 70 causes neuroaxonal dystrophy in rats 2024 ·Frontiers in Neuroscience ·Miyuu Tanaka, (unknown), (unknown), (unknown), (unknown), Daisuke Tanaka, (unknown), Tadao Serikawa, (unknown), (unknown), Tomoji Mashimo, Mitsuru Kuwamura, Jason E. Gestwicki, Takashi Kuramoto	1
10	C–C Motif chemokine receptor-2 blockade ameliorates pulmonary hypertension in rats and synergizes with a pulmonary vasodilator 2024 ·Cardiovascular Research ·(unknown), Hirofumi Sawada, Yoshihide Mitani, (unknown), (unknown), (unknown), (unknown), Yoshiki Miyasaka, (unknown), (unknown), Hiroyuki Ohashi, Junko Maruyama, Ryuji Okamoto, Tomoji Mashimo, Kaoru Dohi, Yuhei Nishimura, Kazuo Maruyama, Masahiro Hirayama	3
11	In vivo18F-DOPA PET imaging identifies a dopaminergic deficit in a rat model with a G51D α-synuclein mutation 2023 ·Frontiers in Neuroscience ·(unknown), Karamjit Singh Dolt, Carlos J. Alcaide‐Corral, (unknown), Christophe Lucatelli, Tomoji Mashimo, Adriana Tavares, Tilo Kunath	3
12	Genome editing technology and applications with the type I CRISPR system 2022 ·Kazuto Yoshimi, Tomoji Mashimo	9
13	BRCA1 haploinsufficiency impairs iron metabolism to promote chrysotile‐induced mesothelioma via ferroptosis resistance 2022 ·Cancer Science ·Yaguang Luo, Shinya Akatsuka, Yashiro Motooka, (unknown), Hao Zheng, Tomoji Mashimo, Tatsuhiko Imaoka, Shinya Toyokuni	7
14	Brca1^L63X^/+ rat is a novel model of human BRCA1 deficiency displaying susceptibility to radiation‐induced mammary cancer 2022 ·Cancer Science ·(unknown), (unknown), Yukiko Nishimura, K. Nagata, Mayumi Nishimura, Kazuhiro Daino, Atsuko Ishikawa, Takehito Kaneko, Tomoji Mashimo, Toshiaki Kokubo, Masaru Takabatake, Kazumasa Inoue, Masahiro Fukushi, Masami Arai, Mitsue Saito, Yoshiya Shimada, Shizuko Kakinuma, Tatsuhiko Imaoka	11
15	CRISPR/Cas9-engineered Gad1 elimination in rats leads to complex behavioral changes: implications for schizophrenia 2020 ·Translational Psychiatry ·Kazuyuki Fujihara, Kazuo Yamada, Yukio Ichitani, Toshikazu Kakizaki, (unknown), Shigeo Miyata, Takashi Suto, Daiki Kato, Shigeru Saito, Masahiko Watanabe, (unknown), Tomokazu Ohshiro, Hajime Mushiake, Yoshiki Miyasaka, Tomoji Mashimo, Hiroki Yasuda, Yuchio Yanagawa	20
16	Generation of knockout rabbits with X-linked severe combined immunodeficiency (X-SCID) using CRISPR/Cas9 2020 ·Scientific Reports ·Yoshiko Hashikawa, Ryuhei Hayashi, (unknown), Toru Okubo, (unknown), Mitsuru Kuwamura, (unknown), (unknown), Yayoi Kunihiro, Tomoji Mashimo, Kohji Nishida	15
17	Pathophysiological significance of Stim1 mutation in sympathetic response to stress and cardiovascular phenotypes in SHRSP/Izm: In vivo evaluation by creation of a novel gene knock-in rat using CRISPR/Cas9 2020 ·Clinical and Experimental Hypertension ·(unknown), (unknown), (unknown), Takehito Kaneko, Yayoi Kunihiro, Tomoji Mashimo, Toru Nabika	2
18	Aspects of Gene Therapy Products Using Current Genome-Editing Technology in Japan 2020 ·Human Gene Therapy ·Teruhide Yamaguchi, Eriko Uchida, Takashi Okada, Keiya Ozawa, Masafumi Onodera, Akihiro Kume, Takashi Shimada, Satoru Takahashi, Kenzaburo Tani, Yasutomo Nasu, Tomoji Mashimo, Hiroyuki Mizuguchi, Kohnosuke Mitani, Kazushige Maki	10
19	A rat model for LGI1-related epilepsies 2012 ·Human Molecular Genetics ·Stéphanie Baulac, Saeko Ishida, Tomoji Mashimo, (unknown), (unknown), Mitsuru Kuwamura, Yukihiro Ohno, Akiko Takizawa, (unknown), Masatsugu Ueda, Akio Ikeda, Éric Leguern, Ryōsuke Takahashi, Tadao Serikawa	31
20	A nonsense mutation in the gene encoding 2′-5′-oligoadenylate synthetase/L1 isoform is associated with West Nile virus susceptibility in laboratory mice 2002 ·Proceedings of the National Academy of Sciences ·Tomoji Mashimo, Marianne Lucas, Dominique Simon‐Chazottes, Marie‐Pascale Frenkiel, Xavier Montagutelli, Pierre‐Emmanuel Ceccaldi, Vincent Deubel, Jean‐Louis Guénet, Philippe Desprès	233

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact